University of Oklahoma clinical trial pipeline

5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.

1. Notable

   Characterizing the Genomic Landscape of Cancer in Native American…Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)

   Primary endpoint(s) modified

   Also in this update: Enrollment increased: 150 → 300 participants; Trial arms changed: 1 → 2

   University of Oklahoma·Not specified· NCT06960798· Registry history of NCT06960798 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.